Tests for agglutinating, precipitating, and immunofluorescent IgM and anti-human-globulin antibody to Candida albicans were performed on 50 blood bank serum specimens, 52 consecutive serum specimens from patients without Candida infection submitted to a fungal serology laboratory, and 17 serum specimens from patients with serious yeast infections. On the basis of a combination of the agglutinin, precipitin, and anti-human-globulin tests, less than 2% of controls, 75% of patients with C. albicans infection, and 40% of those with infections due to other yeasts had clinically significant antibody levels.
No takes yet. Share an insight, caveat, or question.
Dolan et al. (1973) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: